Nohla Therapeutics Announces Second Closing of $56 Million Series B Financing

World News: . []

SEATTLE July 11 2018 GLOBE NEWSWIRE -- Nohla Therapeutics a leading developer of universal off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases, today announced the second closing of its Series B finan...

More news and information about Nohla Therapeutics

Published By:

Globe Newswire: 21:00 GMT Wednesday 11th July 2018

Published: .

Search for other references to "nohla" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us